Germline testing among ovarian cancer patients using an integrated clinical pathway dashboard at Kaiser Permanente, Northern California

被引:0
|
作者
Kavecansky, Juraj [1 ]
Duffens, Ali [1 ]
Brenman, Leslie Manace [1 ]
Garcia, Christine [1 ]
Sun, Hongxin [2 ]
机构
[1] Kaiser Permanente Northern Calif, Walnut Creek, CA USA
[2] Permanente Med Grp Inc, TPMG Consulting Serv, Oakland, CA USA
关键词
D O I
10.1016/j.ygyno.2024.07.218
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
1157
引用
收藏
页码:S148 / S149
页数:2
相关论文
共 47 条
  • [41] Prospective pan-cancer germline testing using MSK-IMPACT informs clinical translation in 751 patients with pediatric solid tumors
    Fiala, Elise M.
    Jayakumaran, Gowtham
    Mauguen, Audrey
    Kennedy, Jennifer A.
    Bouvier, Nancy
    Kemel, Yelena
    Fleischut, Megan Harlan
    Maio, Anna
    Salo-Mullen, Erin E.
    Sheehan, Margaret
    Arnold, Angela G.
    Latham, Alicia
    Carlo, Maria I.
    Cadoo, Karen
    Murkherjee, Semanti
    Slotkin, Emily K.
    Trippett, Tanya
    Glade Bender, Julia
    Meyers, Paul A.
    Wexler, Leonard
    Dela Cruz, Filemon S.
    Cheung, Nai-Kong
    Basu, Ellen
    Kentsis, Alex
    Ortiz, Michael
    Francis, Jasmine H.
    Dunkel, Ira J.
    Khakoo, Yasmin
    Gilheeney, Stephen
    Farouk Sait, Sameer
    Forlenza, Christopher J.
    Sulis, Maria
    Karajannis, Matthias
    Modak, Shakeel
    Gerstle, Justin T.
    Heaton, Todd E.
    Roberts, Stephen
    Yang, Ciyu
    Jairam, Sowmya
    Vijai, Joseph
    Topka, Sabine
    Friedman, Danielle N.
    Stadler, Zsofia K.
    Robson, Mark
    Berger, Michael F.
    Schultz, Nikolaus
    Ladanyi, Marc
    O'Reilly, Richard J.
    Abramson, David H.
    Ceyhan-Birsoy, Ozge
    NATURE CANCER, 2021, 2 (03) : 357 - +
  • [42] Prospective pan-cancer germline testing using MSK-IMPACT informs clinical translation in 751 patients with pediatric solid tumors
    Elise M. Fiala
    Gowtham Jayakumaran
    Audrey Mauguen
    Jennifer A. Kennedy
    Nancy Bouvier
    Yelena Kemel
    Megan Harlan Fleischut
    Anna Maio
    Erin E. Salo-Mullen
    Margaret Sheehan
    Angela G. Arnold
    Alicia Latham
    Maria I. Carlo
    Karen Cadoo
    Semanti Murkherjee
    Emily K. Slotkin
    Tanya Trippett
    Julia Glade Bender
    Paul A. Meyers
    Leonard Wexler
    Filemon S. Dela Cruz
    Nai-Kong Cheung
    Ellen Basu
    Alex Kentsis
    Michael Ortiz
    Jasmine H. Francis
    Ira J. Dunkel
    Yasmin Khakoo
    Stephen Gilheeney
    Sameer Farouk Sait
    Christopher J. Forlenza
    Maria Sulis
    Matthias Karajannis
    Shakeel Modak
    Justin T. Gerstle
    Todd E. Heaton
    Stephen Roberts
    Ciyu Yang
    Sowmya Jairam
    Joseph Vijai
    Sabine Topka
    Danielle N. Friedman
    Zsofia K. Stadler
    Mark Robson
    Michael F. Berger
    Nikolaus Schultz
    Marc Ladanyi
    Richard J. O’Reilly
    David H. Abramson
    Ozge Ceyhan-Birsoy
    Nature Cancer, 2021, 2 : 357 - 365
  • [43] Li-Fraumeni: "Genetic testing of Breast/ovarian cancer patients unmask familial pathogenic germline variants in TP53 gene. Clinical implications and family counselling"
    Zavos, A.
    Natsiopoulos, I.
    Papazisis, K.
    Giassas, S.
    Tsiftsoglou, A.
    Bouzarelou, D.
    Meintani, A.
    Katseli, A.
    Potska, V.
    Dogka, C.
    Tsaousis, G.
    Iosifidou, R.
    Lalla, E.
    Askoxylakis, I.
    Zairi, E.
    Kotsakis, A.
    Tryfonopoulos, D.
    Christopoulou, A.
    Ntokou, A.
    Mandrekas, K.
    Bafaloukos, D.
    Sfika, A.
    Zakopoulou, R.
    Markellou, P.
    Papadopoulou, E.
    Nasioulas, G.
    BREAST, 2025, 80
  • [44] What are the CA-125 testing rates and their clinical implications among patients with advanced ovarian cancer treated in real-world community practice?
    Duska, Linda
    Cooney, Maureen
    Kiss, Zsofia
    Kalilani, Linda
    Golembesky, Amanda
    Schilder, Jeanne
    Hurteau, Jean
    Randall, Leslie
    Song, Jinlin
    Xiang, Cheryl
    Rabideau, Brendan
    Rimel, Bobbie
    GYNECOLOGIC ONCOLOGY, 2024, 190 : S276 - S277
  • [45] Landscape of BRCA1 and BRCA2 germline, somatic, and reversion alterations detectable by cell-free DNA testing among patients with metastatic breast, ovarian, pancreatic, or prostate cancer
    Bardia, Aditya
    Rich, Thereasa A.
    Raymond, Victoria M.
    Fairclough, Stephen R.
    Sartor, A. Oliver
    Lilly, Michael B.
    Nezami, Mohammad
    Patel, Sandip Pravin
    Carneiro, Benedito A.
    Fan, Alice C.
    Brufsky, Adam
    Parker, Barbara A.
    Bridges, Benjamin B.
    Agarwal, Neeraj
    Maughan, Benjamin Louis
    Lanman, Richard B.
    Cristofanilli, Massimo
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [46] Predictors of frequent emergency department visits among hospitalized cancer patients: a comparative cohort study using integrated clinical and administrative data to improve care delivery
    Kurteva, Siyana
    Tamblyn, Robyn
    Meguerditchian, Ari N.
    BMC HEALTH SERVICES RESEARCH, 2023, 23 (01)
  • [47] Predictors of frequent emergency department visits among hospitalized cancer patients: a comparative cohort study using integrated clinical and administrative data to improve care delivery
    Siyana Kurteva
    Robyn Tamblyn
    Ari N. Meguerditchian
    BMC Health Services Research, 23